Abbott GmbH & Co. KG
Knollstrasse 50
67061 Ludwigshafen
Germany

www.abbott.com

Participant's Lead

Georg Terstappen Director and Department Head in Neuroscience Discovery  Contact

Institute Presentation

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  Abbott is actively engaged in conducting trials in schizophrenia, including trials assessing effects of compounds on CIAS.  Abbott has also successfully conducted trials using scales of interest to WP 03 and is in a position to collect and analyse clinical samples relevant to WP 08.  Abbott has extensive experience with behavioural pharmacology and electrophysiology in preclinical species relevant to WP 01 and 02 and can also provide access to novel pharmacological tools for preclinical research relevant to WP 01 and 02.